Opioid abuse and addiction


Physicians Insurance/Experix online continuing medical education on addiction and pain management
These activities has been approved for AMA PRA Category 1 Credit™.

A Leader’s Guide
A Leader’s Guide is a shared effort delivered by ControlRx on behalf of Experix, a wholly owned subsidiary of Physicians Insurance A Mutual Company. Your course director is Michael Schiesser MD, an internist and addiction medicine specialist practicing in the state of Washington.

ROAM and ECHO: Defeating Opiate Addiction in Rural Washington
Two initiatives to help providers grapple with the disparate problems of addiction and pain management. ROAM (the Rural Opiate Addiction Management) Collaborative, launched by UW Medicine and Washington State University, seeks to help manage the widespread issue of opiate addiction in rural Washington. COPE (Collaborative Opioid Prescribing Education), launched by UW Medicine is an online educational tool that helps providers communicate to patients about how best to manage treatment of chronic, non-cancer-related pain.

SAMHSA (Substance Abuse and Mental Health Services Administration) opioid courses and buprenorphine training
SAMHSA is the agency within the U.S. Department of Health and Human Services that leads public health efforts to reduce the impact of substance abuse and mental illness.

Webinar | Addiction, Stigma and Discrimination: Implications for Treatment and Recovery
Providers’ Clinical Support System for Medication Assisted Treatment

CME | Stigma in Methadone and Buprenorphine Maintenance Treatment
Providers’ Clinical Support System for Medication Assisted Treatment

Webinars & Activities | Substance Use Disorders
The American Psychiatric Association

CME | Featured Courses on MAT and Pain Management
The American Psychiatric Association

CME | DATA 2000 8 Hour Waiver Qualifying Buprenorphine Training
The American Society of Addiction Medicine

CME | Buprenorphine Waiver Training
The American Academy of Addiction Psychiatry

Webinar | MAT Office-Based Treatment of Opioid Dependence
Providers’ Clinical Support System for Medication Assisted Treatment Self Study at the American Osteopathic Academy of Addiction Medicine


What physicians need to know about recent federal policy changes, including the Comprehensive Addiction and Recovery Act (CARA) of 2016 (Updated Nov. 2016)
With passage of CARA, and changes made by the Substance Abuse and Mental Health Services Administration’s final rule, Congress and the White House have made a number of policy changes to combat the opioid epidemic—some of which physicians can leverage immediately. To bring members up to speed, the WSMA has prepared this guidance document, which contains information on federal policy changes, particularly those that address medication-assisted treatment (MAT)—the use of medications together with behavioral therapy to treat substance use disorders. The guidance includes new information on patient limits, which practitioners can prescribe buprenorphine, and partial prescription fills for controlled substances.

Recommendations on co-prescribing naloxone
The AMA offers recommendations for when you should consider co-prescribing naloxone to your patients.

Barriers to Treatment
Providers’ Clinical Support System for Medication Assisted Treatment

National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
American Society of Addiction Medicine

Committee Opinion | Opioid Abuse, Dependence, and Addiction in Pregnancy
Committee Opinion | Substance Abuse Reporting and Pregnancy: The Role of the Obstetrician-Gynecologist
Committee Opinion | Nonmedical Use of Prescription Drugs
American Congress of Obstetricians and Gynecologists

Healthcare Brief | Medication-Assisted Treatment for Opioid Addiction
Office of National Drug Control Policy